PHI with Tick-borne encephalitis vaccination
How does this condition affect your private health insurance?
The "Zeckenbissimpfung" refers to the vaccination against Tick-borne encephalitis (TBE), a viral infection affecting the central nervous system, transmitted through tick bites. This prophylactic measure involves a series of inactivated virus injections designed to stimulate immunity. A primary course usually consists of two to three doses, followed by regular booster shots every three to five years, depending on the vaccine type and national guidelines. It is strongly recommended for individuals residing in or traveling to TBE-endemic regions. Common, mild side effects include local pain, swelling, fever, or headache, typically resolving within 1-2 days. Serious adverse events are extremely rare.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically 1-2 days for mild post-vaccination reactions like fever or soreness at the injection site.
Duration of Illness (Lifetime)
Intermittent, short-lived episodes (1-2 days) of mild side effects following each dose or booster; not a chronic condition.
Cost of Treatment (Initial)
Approximately 50-70 EUR per dose for the vaccine itself, excluding administration fees.
Cost of Treatment (Lifetime)
Estimated 200-500 EUR for a full primary series and subsequent boosters over a lifetime, varying by region and number of doses.
Mortality Rate
Extremely low, estimated to be less than 1 in several million doses administered.
Risk of Secondary Damages
Very low; severe allergic reactions (anaphylaxis) are rare (approximately 1 in a million doses); neurological complications are exceedingly rare.
Probability of Full Recovery
Nearly 100% for mild vaccine side effects; for extremely rare severe reactions, recovery can be complete or may involve long-term management.
Underlying Disease Risk
Low, as severe acute or chronic underlying diseases are generally contraindications, leading to vaccine deferral.